Apellis Pharmaceuticals, Inc.
NASDAQ:APLS
24.66 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 411.29 | 351.185 | 551.801 | 640.192 | 565.779 | 351.985 | 176.268 | 175.644 | 24.863 | 36.004 | 13.623 | 4.758 |
| Short Term Investments
| 0 | 1.114 | 6.505 | 60.358 | 311.869 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 411.29 | 352.299 | 551.801 | 700.55 | 877.648 | 351.985 | 176.268 | 175.644 | 24.863 | 36.004 | 13.623 | 4.758 |
| Net Receivables
| 264.926 | 206.442 | 7.727 | 10.103 | 25 | 0 | 0 | 0 | 0 | 0 | 0.466 | 0.067 |
| Inventory
| 81.404 | 146.362 | 85.714 | 16.286 | 0 | 0 | 0 | 0 | 0 | 0 | 0.137 | 0.343 |
| Other Current Assets
| 31.334 | 61.228 | 73.008 | 97.108 | 14.544 | 21.11 | 26.172 | 6.372 | 2.505 | 2.04 | 0.158 | 0.365 |
| Total Current Assets
| 788.954 | 766.331 | 719.523 | 824.047 | 917.192 | 373.095 | 202.439 | 182.015 | 27.369 | 38.044 | 14.247 | 5.19 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 19.035 | 21.09 | 24.895 | 26.078 | 24.522 | 15.765 | 0.978 | 0 | 0 | 0 | 0.022 | 0.009 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 3.24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 77.062 | -1.931 | 15.799 | 31.64 | 18.855 | 0.385 | 0.116 | 0.116 | 0.065 | 0.133 | 0.037 | 0 |
| Total Non-Current Assets
| 96.097 | 22.399 | 40.694 | 57.718 | 43.377 | 16.15 | 1.094 | 0.116 | 0.065 | 0.133 | 0.059 | 0.009 |
| Total Assets
| 885.051 | 788.73 | 760.217 | 881.765 | 960.569 | 389.245 | 203.534 | 182.131 | 27.433 | 38.177 | 14.306 | 5.199 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 38.572 | 37.516 | 37.342 | 16.909 | 8.477 | 8.361 | 10.255 | 3.663 | 2.547 | 2.477 | 0.752 | 0.354 |
| Short Term Debt
| 13.506 | 6.441 | 5.625 | 4.115 | 3.685 | 5.218 | 1.667 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 103.239 | 111.935 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 133.431 | 203.636 | 124.643 | 110.823 | 116.165 | 52.173 | 5.103 | 2.891 | 1.092 | 0.723 | 0.33 | 0.323 |
| Total Current Liabilities
| 185.509 | 247.593 | 167.61 | 131.847 | 128.327 | 65.753 | 17.025 | 6.554 | 3.639 | 3.2 | 1.082 | 0.677 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 463.031 | 104.487 | 107.088 | 206.105 | 374.047 | 154.423 | 25.378 | 26.39 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 7.972 | 242.129 | 315.647 | 345.151 | 253.638 | 134.839 | 0.159 | 0.244 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 471.003 | 346.616 | 422.735 | 551.256 | 627.685 | 289.262 | 25.536 | 26.635 | 0 | 0 | 0 | 0 |
| Total Liabilities
| 656.512 | 594.209 | 590.345 | 683.103 | 756.012 | 355.015 | 42.561 | 33.189 | 3.639 | 3.2 | 1.082 | 0.677 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 92.055 | 77.192 | 35.864 | 16.761 |
| Common Stock
| 0.012 | 0.012 | 0.011 | 0.01 | 0.008 | 0.006 | 0.006 | 0.005 | 0.001 | 0.001 | 0.001 | 0.001 |
| Retained Earnings
| -3,035.366 | -2,837.488 | -2,308.86 | -1,656.688 | -926.347 | -581.472 | -276.766 | -149.264 | -98.258 | -71.133 | -24.617 | -13.828 |
| Accumulated Other Comprehensive Income/Loss
| -3.308 | -3.542 | -0.875 | -2.09 | -0.117 | -0.154 | -0.123 | 0 | 0 | -0 | -0.022 | -0.016 |
| Other Total Stockholders Equity
| 3,267.201 | 3,035.539 | 2,479.596 | 1,857.43 | 1,131.013 | 615.85 | 437.856 | 298.201 | 29.996 | 28.916 | 1.974 | 1.315 |
| Total Shareholders Equity
| 228.539 | 194.521 | 169.872 | 198.662 | 204.557 | 34.23 | 160.973 | 148.943 | 23.794 | 34.977 | 13.225 | 4.523 |
| Total Equity
| 228.539 | 194.521 | 169.872 | 198.662 | 204.557 | 34.23 | 160.973 | 148.943 | 23.794 | 34.977 | 13.225 | 4.523 |
| Total Liabilities & Shareholders Equity
| 885.051 | 788.73 | 760.217 | 881.765 | 960.569 | 389.245 | 203.534 | 182.131 | 27.433 | 38.177 | 14.306 | 5.199 |